The association of serotonin reuptake inhibitors and benzodiazepines with ictal central apnea.


Journal

Epilepsy & behavior : E&B
ISSN: 1525-5069
Titre abrégé: Epilepsy Behav
Pays: United States
ID NLM: 100892858

Informations de publication

Date de publication:
09 2019
Historique:
received: 08 04 2019
revised: 14 06 2019
accepted: 15 06 2019
pubmed: 14 7 2019
medline: 8 7 2020
entrez: 14 7 2019
Statut: ppublish

Résumé

Ictal (ICA) and postconvulsive central apnea (PCCA) have been implicated in sudden unexpected death in epilepsy (SUDEP) pathomechanisms. Previous studies suggest that serotonin reuptake inhibitors (SRIs) and benzodiazepines (BZDs) may influence breathing. The aim of this study was to investigate if chronic use of these drugs alters central apnea occurrence in patients with epilepsy. Patients with epilepsy admitted to epilepsy monitoring units (EMUs) in nine centers participating in a SUDEP study were consented. Polygraphic physiological parameters were analyzed, including video-electroencephalography (VEEG), thoracoabdominal excursions, and pulse oximetry. Outpatient medication details were collected. Patients and seizures were divided into SRI, BZD, and control (no SRI or BZD) groups. Ictal central apnea and PCCA, hypoxemia, and electroclinical features were assessed for each group. Four hundred and seventy-six seizures were analyzed (204 patients). The relative risk (RR) for ICA in the SRI group was half that of the control group (p = 0.02). In the BZD group, ICA duration was significantly shorter than in the control group (p = 0.02), as was postictal generalized EEG suppression (PGES) duration (p = 0.021). Both SRI and BZD groups were associated with smaller seizure-associated oxygen desaturation (p = 0.009; p ≪ 0.001). Neither presence nor duration of PCCA was significantly associated with SRI or BZD (p ≫ 0.05). Seizures in patients taking SRIs have lower occurrence of ICA, and patients on chronic treatment with BZDs have shorter ICA and PGES durations. Preventing or shortening ICA duration by using SRIs and/or BZD in patients with epilepsy may play a possible role in SUDEP risk reduction.

Identifiants

pubmed: 31301453
pii: S1525-5050(19)30335-X
doi: 10.1016/j.yebeh.2019.06.029
pmc: PMC8975169
mid: NIHMS1532562
pii:
doi:

Substances chimiques

Serotonin Uptake Inhibitors 0
Benzodiazepines 12794-10-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

73-79

Subventions

Organisme : NINDS NIH HHS
ID : U01 NS090405
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS090407
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS090414
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

Epilepsia. 2018 Apr;59(4):e56-e62
pubmed: 29601086
Epilepsia. 2016 Mar;57(3):412-7
pubmed: 26763069
Epilepsia. 2006 Jan;47(1):21-6
pubmed: 16417527
Epilepsia. 2017 Nov;58(11):2002-2009
pubmed: 28944447
Neurology. 2018 Oct 16;91(16):e1508-e1518
pubmed: 30242018
Neurology. 2019 Jan 15;92(3):e171-e182
pubmed: 30568003
Dev Med Child Neurol. 2005 Jan;47(1):4-9
pubmed: 15686283
Annu Rev Neurosci. 2003;26:239-66
pubmed: 12598679
Br J Anaesth. 2008 Jun;100(6):747-58
pubmed: 18456641
Epilepsia. 2018 Mar;59(3):573-582
pubmed: 29336036
Chest. 1996 Apr;109(4):909-15
pubmed: 8635369
Annu Rev Pathol. 2009;4:517-50
pubmed: 19400695
Seizure. 1994 Sep;3(3):221-4
pubmed: 8000717
Neuroimage Clin. 2018 Jul 18;20:205-215
pubmed: 30094170
Neurology. 2017 Feb 14;88(7):701-705
pubmed: 28087822
Naunyn Schmiedebergs Arch Pharmacol. 1976 Jul;294(1):1-7
pubmed: 12477
Br J Pharmacol. 2012 May;166(1):339-48
pubmed: 22044283
Lancet Neurol. 2016 Sep;15(10):1075-88
pubmed: 27571159
Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18208-13
pubmed: 20921395
Mol Cell Biochem. 1981 Aug 11;38 Spec No(Pt 1):147-62
pubmed: 6270545
Sleep. 1990 Feb;13(1):31-41
pubmed: 2406849
Epilepsy Behav. 2011 Oct;22(2):401-3
pubmed: 21816679
Epilepsy Behav. 2016 Aug;61:282-286
pubmed: 27236241
Brain. 2018 Jun 1;141(6):1719-1733
pubmed: 29608654
Epilepsia. 2010 Oct;51(10):2211-4
pubmed: 20491872
J Neurol Neurosurg Psychiatry. 2000 Feb;68(2):211-3
pubmed: 10644790
Ann Neurol. 2018 Mar;83(3):460-471
pubmed: 29420859
Neurology. 2019 Feb 12;92(7):e655-e669
pubmed: 30635481
Epilepsia. 1999 Apr;40(4):492-6
pubmed: 10219277
J Neurosci. 2015 Jul 15;35(28):10281-9
pubmed: 26180203
Front Neurol. 2019 Mar 01;10:166
pubmed: 30890997
Lancet Neurol. 2013 Oct;12(10):966-77
pubmed: 24012372
Epilepsy Behav. 2014 Mar;32:142-4
pubmed: 24561659
JAMA. 2006 Nov 1;296(17):2124-32
pubmed: 17077377
Epilepsy Behav. 2016 Nov;64(Pt A):166-170
pubmed: 27743549
Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16354-9
pubmed: 20805497
Ann Neurol. 2010 Dec;68(6):787-96
pubmed: 20882604
Nat Genet. 1997 Aug;16(4):387-90
pubmed: 9241279
Neurosci Behav Physiol. 2010 Feb;40(2):165-71
pubmed: 20033306
Epilepsia. 2017 Jul;58(7):1268-1276
pubmed: 28555776
Brain. 2015 Oct;138(Pt 10):2907-19
pubmed: 26264515
J Neurol Neurosurg Psychiatry. 1996 Mar;60(3):297-300
pubmed: 8609507
Epilepsia. 2010 Jun;51(6):1069-77
pubmed: 19889013
Br J Anaesth. 1981 Oct;53(10):1059-63
pubmed: 6794583
Front Neurol. 2017 Oct 16;8:544
pubmed: 29085330
IEEE Trans Biomed Eng. 2018 Feb;65(2):371-377
pubmed: 29346105
eNeuro. 2016 May 13;3(2):
pubmed: 27200412
Nat Rev Neurosci. 2004 Jun;5(6):449-61
pubmed: 15152195
Epilepsy Behav. 2015 Apr;45:1-7
pubmed: 25771493
J Physiol. 2014 Oct 1;592(19):4395-410
pubmed: 25107926
Nat Rev Neurol. 2014 May;10(5):271-82
pubmed: 24752120
Pharmacol Ther. 2000 Jun;86(3):277-304
pubmed: 10882812
Neuroimage Clin. 2014 Jul 09;5:208-16
pubmed: 25068110

Auteurs

Nuria Lacuey (N)

Epilepsy Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA. Electronic address: nurialacuey@yahoo.es.

Rita Martins (R)

Hospital Prof. Doutor Fernando Fonseca, Amadora, Portugal.

Laura Vilella (L)

NINDS Center for SUDEP Research (CSR), Cleveland, OH, USA.

Johnson P Hampson (JP)

Epilepsy Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

M R Sandhya Rani (MRS)

NINDS Center for SUDEP Research (CSR), Cleveland, OH, USA.

Kingman Strohl (K)

Division of Pulmonary, Critical Care and Sleep Medicine, University Hospitals Medical Center, Cleveland, OH, USA.

Anita Zaremba (A)

NINDS Center for SUDEP Research (CSR), Cleveland, OH, USA.

Jaison S Hampson (JS)

NINDS Center for SUDEP Research (CSR), Cleveland, OH, USA.

Rup K Sainju (RK)

NINDS Center for SUDEP Research (CSR), Cleveland, OH, USA; University of Iowa Carver College of Medicine, Iowa City, IA, USA.

Daniel Friedman (D)

NINDS Center for SUDEP Research (CSR), Cleveland, OH, USA; NYU Langone School of Medicine, New York, NY, USA.

Maromi Nei (M)

NINDS Center for SUDEP Research (CSR), Cleveland, OH, USA; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.

Catherine Scott (C)

NINDS Center for SUDEP Research (CSR), Cleveland, OH, USA; Institute of Neurology, University College London, London, UK.

Brian K Gehlbach (BK)

NINDS Center for SUDEP Research (CSR), Cleveland, OH, USA; University of Iowa Carver College of Medicine, Iowa City, IA, USA.

Norma J Hupp (NJ)

NINDS Center for SUDEP Research (CSR), Cleveland, OH, USA.

Stephan Schuele (S)

NINDS Center for SUDEP Research (CSR), Cleveland, OH, USA; Northwestern University, Feinberg School of Medicine, Chicago, USA.

Jennifer Ogren (J)

NINDS Center for SUDEP Research (CSR), Cleveland, OH, USA; Department of Neurobiology and the Brain Research Institute, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.

Ronald M Harper (RM)

Hospital Prof. Doutor Fernando Fonseca, Amadora, Portugal; Department of Neurobiology and the Brain Research Institute, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.

Luke Allen (L)

NINDS Center for SUDEP Research (CSR), Cleveland, OH, USA; Institute of Neurology, University College London, London, UK.

Beate Diehl (B)

NINDS Center for SUDEP Research (CSR), Cleveland, OH, USA; Institute of Neurology, University College London, London, UK.

Lisa M Bateman (LM)

NINDS Center for SUDEP Research (CSR), Cleveland, OH, USA; Department of Neurology, Columbia University, New York, NY, USA.

Orrin Devinsky (O)

NINDS Center for SUDEP Research (CSR), Cleveland, OH, USA; NYU Langone School of Medicine, New York, NY, USA.

George B Richerson (GB)

NINDS Center for SUDEP Research (CSR), Cleveland, OH, USA; University of Iowa Carver College of Medicine, Iowa City, IA, USA.

Samden Lhatoo (S)

Epilepsy Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA; NINDS Center for SUDEP Research (CSR), Cleveland, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH